| 1 |
24657894 | Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia. | 2014 May 2 |
2 |
| 2 |
23534290 | Biochemical effects of combined action of gamma-irradiation and paclitaxel on anaplastic thyroid cancer cells. | 2013 Jan-Feb |
1 |
| 3 |
24155950 | Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells. | 2013 |
1 |
| 4 |
22765290 | Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents. | 2012 Oct |
1 |
| 5 |
21813412 | The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells. | 2011 Sep 21 |
1 |
| 6 |
22110595 | Long circulating lectin conjugated paclitaxel loaded magnetic nanoparticles: a new theranostic avenue for leukemia therapy. | 2011 |
1 |
| 7 |
14670960 | Bcr-Abl regulates protein kinase Ciota (PKCiota) transcription via an Elk1 site in the PKCiota promoter. | 2004 Mar 5 |
1 |
| 8 |
15548364 | Multiple stress signals induce p73beta accumulation. | 2004 Sep-Oct |
1 |
| 9 |
12694868 | Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells. | 2003 Apr 15 |
2 |
| 10 |
11521190 | NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival. | 2001 Aug 9 |
2 |
| 11 |
11587211 | The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy. | 2001 Oct |
2 |
| 12 |
9933579 | Protein kinase Ciota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis. | 1999 Feb 12 |
3 |